A study identified the mutation mechanism LTA chromothripsis in 50% of high-grade osteosarcoma cases, explaining its genomic ...

Study identifies a novel mechanism driving osteosarcoma and provides insights to help predict patient outcomes ...

A new study reveals a mutation mechanism in osteosarcoma, promising advances in treatment and prognosis for this challenging ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a ...

The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more ...

The large-cap stock picks are Lupin, Zomato, and Tata Motors, while the mid-cap stock picks include IndusInd Bank, Escorts, ...

Moody National Bank Trust Division grew its position in shares of Helmerich & Payne, Inc. (NYSE:HP – Free Report) by 19.3% in ...

B. Riley upgraded shares of Ulta Beauty (NASDAQ:ULTA – Free Report) from a sell rating to a neutral rating in a report published on Tuesday, Marketbeat Ratings reports. The brokerage currently has ...

Osteosarcoma is the most common primary cancer of the bone, with a peak incidence in children and young adults. Researchers ...

Air Nostrum may become the launch customer for the new Airlander 10 airship, where Zeppelins meet the future of net-zero ...

A new mutation mechanism, called loss-translocation-amplification (LTA) chromothripsis, which is present in approximately 50% of high-grade osteosarcoma cases.